<li id="quy4e"></li>
<button id="quy4e"></button>
  • <button id="quy4e"><bdo id="quy4e"></bdo></button>
    <rt id="quy4e"></rt>
    <tfoot id="quy4e"></tfoot>
  • 咨詢熱線

    15000266580

    當(dāng)前位置:首頁(yè)  >  技術(shù)文章  >  OVCAR-3 人卵巢腺癌細(xì)胞的介紹

    OVCAR-3 人卵巢腺癌細(xì)胞的介紹

    更新時(shí)間:2014-08-22      點(diǎn)擊次數(shù):4526

    OVCAR-3 人卵巢腺癌細(xì)胞的介紹

    形態(tài)特性:上皮細(xì)胞樣
    生長(zhǎng)特性: 貼壁生長(zhǎng)
    特征特性:OVCAR-3細(xì)胞源自一名60歲白人女性卵巢腫瘤組織,由T.C.Hamiltonyu建系于1982年。該細(xì)胞帶有雌、雄激素受體。對(duì)阿霉素,順氯氨鉑,(左旋)苯丙氨酸氮芥有一定抗藥性,適用于卵巢癌的抗藥性研究。OVCAR-3染色體數(shù)量在亞三倍體范圍內(nèi)。
    傳代方法: 1:3傳代,2-3天傳一代
    支原體檢測(cè):陰性
    此細(xì)胞為我公司走ATCC保藏中心引進(jìn),以下是ATCC介紹
    NIH:OVCAR-3 [OVCAR3] (ATCC® HTB-161)
     

    OrganismHomo sapiens, human
    Tissueovary
    Cell Typeepithelial
    Product Formatfrozen
    Morphologyepithelial
    Culture Propertiesadherent
    Biosafety Level1
    Diseaseadenocarcinoma
    Age60 years
    Genderfemale
    EthnicityCaucasian
    Applications

    This cell line is a suitable transfection host.

    NIH:OVCAR-3 is an appropriate model system in which to study drug resistance in ovarian cancer, and the presence of hormone receptors should be useful for the evaluation of hormonal therapy.

    Storage Conditions

    liquid nitrogen vapor temperature

    Derivation

    The NIH:OVCAR-3 line was established in 1982 by T.C. Hamilton, et al. from the malignant ascites of a patient with progressive adenocarcinoma of the ovary.

    Clinical Data

    Caucasian

    female

    60 years

    Receptor ExpressionAndrogen receptor, positive; estrogen receptor, positive; progesterone receptor, positive
    TumorigenicYes
    Effects

    Yes, Forms colonies in soft agar

    Yes, in nude mice inoculated subcutaneously with 10(7) cells

    (Tumors developed within 21 days at 100% frequency (5/5).)

    Comments

    Forms colonies in soft agar and has an abnormal karyotype.

    Resistant to clinically relevant concentrations of adriamycin, melphalan and cisplatin.

    Both cultured cells and xenografts exhibit androgen and estrogen receptors.

    Xenograft models have been used to show that treatment with 17 beta estradiol can induce progesterone receptors in this human ovarian carcinoma.

    KaryotypeThe cell line is aneuploid human female, with chromosome counts in the sub to near-triploid range. Several normal chromosomes (N11, N13, N14, N15, N16, N17, and N22) are clearly under-represented. Many of these missing chromosomes are represented in the large number of cytogenetically altered chromosomes identified as marker chromosomes. In addition to the marker chromosomes, there are a large number of other structurally abnormal and unassignable chromosomes that are not recognized as markers. Random loss and gain of chromosomes from cell to cell are noted in the exact chromosome counts and in the analysis of the karyotypes.
    聯(lián)系方式

    郵箱:xiangfbio@163.com

    地址:上海市虹口區(qū)四平路710號(hào)7層

    咨詢熱線

    400-821-8510

    (周一至周日9:00- 19:00)

    在線咨詢
    • 掃一掃 微信咨詢

    Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
    技術(shù)支持:化工儀器網(wǎng)    管理登陸
    主站蜘蛛池模板: 田林县| 衡南县| 陵水| 汕头市| 岚皋县| 怀化市| 西和县| 合肥市| 静海县| 苍南县| 确山县| 湘乡市| 县级市| 民丰县| 平利县| 当雄县| 大新县| 嘉鱼县| 定南县| 乐昌市| 安徽省| 邮箱| 酒泉市| 中山市| 台安县| 舟曲县| 绩溪县| 柯坪县| 平阳县| 嘉义市| 永安市| 洛隆县| 海伦市| 蕲春县| 伊吾县| 邢台市| 根河市| 瑞安市| 吴江市| 博兴县| 虞城县|